1. Home
  2. BCDA vs ZKIN Comparison

BCDA vs ZKIN Comparison

Compare BCDA & ZKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • ZKIN
  • Stock Information
  • Founded
  • BCDA N/A
  • ZKIN 2015
  • Country
  • BCDA United States
  • ZKIN China
  • Employees
  • BCDA N/A
  • ZKIN N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • ZKIN Metal Fabrications
  • Sector
  • BCDA Health Care
  • ZKIN Industrials
  • Exchange
  • BCDA Nasdaq
  • ZKIN Nasdaq
  • Market Cap
  • BCDA 11.0M
  • ZKIN 12.6M
  • IPO Year
  • BCDA N/A
  • ZKIN 2017
  • Fundamental
  • Price
  • BCDA $2.12
  • ZKIN $2.18
  • Analyst Decision
  • BCDA Strong Buy
  • ZKIN
  • Analyst Count
  • BCDA 1
  • ZKIN 0
  • Target Price
  • BCDA $25.00
  • ZKIN N/A
  • AVG Volume (30 Days)
  • BCDA 204.0K
  • ZKIN 33.0K
  • Earning Date
  • BCDA 08-12-2025
  • ZKIN 01-27-2025
  • Dividend Yield
  • BCDA N/A
  • ZKIN N/A
  • EPS Growth
  • BCDA N/A
  • ZKIN N/A
  • EPS
  • BCDA N/A
  • ZKIN N/A
  • Revenue
  • BCDA $3,000.00
  • ZKIN $108,199,877.00
  • Revenue This Year
  • BCDA N/A
  • ZKIN N/A
  • Revenue Next Year
  • BCDA N/A
  • ZKIN N/A
  • P/E Ratio
  • BCDA N/A
  • ZKIN N/A
  • Revenue Growth
  • BCDA N/A
  • ZKIN N/A
  • 52 Week Low
  • BCDA $1.63
  • ZKIN $0.82
  • 52 Week High
  • BCDA $4.66
  • ZKIN $6.30
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 44.60
  • ZKIN 49.65
  • Support Level
  • BCDA $1.98
  • ZKIN $1.90
  • Resistance Level
  • BCDA $2.45
  • ZKIN $2.34
  • Average True Range (ATR)
  • BCDA 0.16
  • ZKIN 0.17
  • MACD
  • BCDA -0.01
  • ZKIN -0.02
  • Stochastic Oscillator
  • BCDA 18.00
  • ZKIN 56.90

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

Share on Social Networks: